Business Description
Enovis Corp
NAICS : 339112
SIC : 3845
ISIN : US1940141062
Share Class Description:
FRA:C520: Ordinary SharesTotal Employee Number:
7,802Description
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | -1.83 | |||||
Interest Coverage | 0.96 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.34 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.9 | |||||
3-Year EPS without NRI Growth Rate | 13.3 | |||||
3-Year Book Growth Rate | -25.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.75 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.01 | |||||
9-Day RSI | 36.45 | |||||
14-Day RSI | 39.83 | |||||
3-1 Month Momentum % | -5.08 | |||||
6-1 Month Momentum % | -17.26 | |||||
12-1 Month Momentum % | -34.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.04 | |||||
Quick Ratio | 1.05 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 244.57 | |||||
Days Sales Outstanding | 70.75 | |||||
Days Payable | 81.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -0.14 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60.51 | |||||
Operating Margin % | 1.46 | |||||
Net Margin % | -49.92 | |||||
EBITDA Margin % | -33.81 | |||||
FCF Margin % | 1.55 | |||||
OCF Margin % | 10.63 | |||||
ROE % | -55.84 | |||||
ROA % | -25.85 | |||||
ROIC % | 0.84 | |||||
3-Year ROIIC % | -12.83 | |||||
ROC (Joel Greenblatt) % | -85.86 | |||||
ROCE % | -27.82 | |||||
Years of Profitability over Past 10-Year | 5 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 5.49 | |||||
PE Ratio without NRI | 6.66 | |||||
PS Ratio | 0.57 | |||||
PB Ratio | 0.88 | |||||
Price-to-Free-Cash-Flow | 35.16 | |||||
Price-to-Operating-Cash-Flow | 5.31 | |||||
EV-to-EBIT | -2.65 | |||||
EV-to-Forward-EBIT | 8.68 | |||||
EV-to-EBITDA | -3.66 | |||||
EV-to-Forward-EBITDA | 5.87 | |||||
EV-to-Revenue | 1.24 | |||||
EV-to-Forward-Revenue | 1.14 | |||||
EV-to-FCF | 74.47 | |||||
Price-to-GF-Value | 0.45 | |||||
Price-to-Projected-FCF | 0.87 | |||||
Price-to-Median-PS-Value | 0.56 | |||||
Earnings Yield (Greenblatt) % | -37.73 | |||||
FCF Yield % | 2.47 | |||||
Forward Rate of Return (Yacktman) % | -15.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Enovis Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,958.447 | ||
| EPS (TTM) (€) | -16.967 | ||
| Beta | 0.7193 | ||
| 3-Year Sharpe Ratio | -0.8 | ||
| 3-Year Sortino Ratio | -1 | ||
| Volatility % | 33.22 | ||
| 14-Day RSI | 39.83 | ||
| 14-Day ATR (€) | 0.628246 | ||
| 20-Day SMA (€) | 18.88 | ||
| 12-1 Month Momentum % | -34.15 | ||
| 52-Week Range (€) | 17.4 - 30.6 | ||
| Shares Outstanding (Mil) | 57.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enovis Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enovis Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 126 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 125 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 35 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 34 days | ||
| General meeting for 2026 | 2026-05-19 12:00 | 20.40 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:30 | 20.40 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 20.40 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 08:30 | 19.20 (+0.00%) | ||
| Annual report for 2025 | 2026-02-26 | 19.20 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 19.20 (+0.00%) |
Show
Entries
Enovis Corp Frequently Asked Questions
What is Enovis Corp(FRA:C520)'s stock price today?
The current price of FRA:C520 is €20.00. The 52 week high of FRA:C520 is €30.60 and 52 week low is €17.40.
When is next earnings date of Enovis Corp(FRA:C520)?
The next earnings date of Enovis Corp(FRA:C520) is 2026-08-07 Est..
Does Enovis Corp(FRA:C520) pay dividends? If so, how much?
Enovis Corp(FRA:C520) does not pay dividend.
Press Release
Articles on Enovis Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers